CA1340548C - Methode de production de gp 160 de vih native - Google Patents

Methode de production de gp 160 de vih native

Info

Publication number: CA1340548C
Authority: CA; Canada
Prior art keywords: hiv; cells; serum; cell; medium
Prior art date: 1988-08-16
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

CA 608327

Other languages

English (en)

Inventor

Mangalasseril G. Sarngadharan

Vaniambadi S. Kalyanaraman

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Akzo NV

Original Assignee

Akzo NV

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-08-16

Filing date

1989-08-15

Publication date

1999-05-18

1989-08-15 Application filed by Akzo NV filed Critical Akzo NV

1999-05-18 Application granted granted Critical

1999-05-18 Publication of CA1340548C publication Critical patent/CA1340548C/fr

2016-05-18 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Landscapes

Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

CA 608327 1988-08-16 1989-08-15 Methode de production de gp 160 de vih native Expired - Lifetime CA1340548C (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US23285988A	1988-08-16	1988-08-16
US07/232,859		1988-08-16

Publications (1)

Publication Number	Publication Date
CA1340548C true CA1340548C (fr)	1999-05-18

Family

ID=22874902

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA 608327 Expired - Lifetime CA1340548C (fr)	1988-08-16	1989-08-15	Methode de production de gp 160 de vih native

Country Status (4)

Country	Link
JP (1)	JP2810179B2 (fr)
CA (1)	CA1340548C (fr)
IE (1)	IE68310B1 (fr)
ZA (1)	ZA896266B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4652599A (en) *	1984-04-23	1987-03-24	The United States Of America As Represented By The Department Of Health And Human Services	Method of continuous production of retroviruses (HTLV-III) from patients with AIDS and pre-AIDS using permissive cells

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS61233700A (ja) *	1984-12-24	1986-10-17	ジエネンテク，インコ−ポレイテツド	分子クロ−ンされたエイズ関連ポリペプチド

1989
- 1989-08-10 JP JP1508913A patent/JP2810179B2/ja not_active Expired - Lifetime
- 1989-08-14 IE IE261289A patent/IE68310B1/en not_active IP Right Cessation
- 1989-08-15 CA CA 608327 patent/CA1340548C/fr not_active Expired - Lifetime
- 1989-08-16 ZA ZA896266A patent/ZA896266B/xx unknown

Also Published As

Publication number	Publication date
ZA896266B (en)	1990-06-27
JPH04501654A (ja)	1992-03-26
JP2810179B2 (ja)	1998-10-15
IE892612L (en)	1990-02-16
IE68310B1 (en)	1996-06-12

Similar Documents

Publication	Publication Date	Title
US6328973B1 (en)	2001-12-11	Method of raising neutralizing antibodies against HIV
EP0327801A1 (fr)	1989-08-16	Rétrovirus du type HIV-2 de primates, et compositions diagnostiques et pharmaceutiques
US6013484A (en)	2000-01-11	HIV-3 retrovirus and its use
US4722888A (en)	1988-02-02	Cell line producing human monoclonal antibody which binds to HTLV-I producing cells
US6608179B1 (en)	2003-08-19	Antibodies, that bind to HIV-2 transmembrane glycoprotein homodimer (gp 80)
KALYANARAMAN et al.	1988	A unique human immunodeficiency virus culture secreting soluble gpl60
EP0394386B1 (fr)	1995-09-06	Procede de production de la glycoproteine gp160 du vih naturel
US5516895A (en)	1996-05-14	Antibodies specific towards gp 48
CA1340548C (fr)	1999-05-18	Methode de production de gp 160 de vih native
US5122468A (en)	1992-06-16	Hut-78 cell lines infected with HTLV-III which secrete gp160
WO1989010416A1 (fr)	1989-11-02	PEPTIDES PROTECTEURS DERIVES DU VIRUS-1 gp160 D'IMMUNODEFICIENCE HUMAIN
Getchell et al.	1986	Continuous production of a cytopathic human T-lymphotropic virus in a permissive neoplastic T-cell line
EP0246101A2 (fr)	1987-11-19	Protéine, ayant une activité antigénique de HTLV-I, ainsi que sa préparation
Mbemba et al.	1994	Interactions of HIV-1 and HIV-2 envelope glycoproteins with sulphated polysaccharides and mannose-6-phosphate
JP2008156350A (ja)	2008-07-10	Ｈｉｖ−２型ヒトレトロウイルスのトランスメンブランエンベロープ糖タンパク質の抗原、及び、該抗原に免疫類似性を有する抗原
AU653926B2 (en)	1994-10-20	HIV-1 ENV fragment fusion protein
EP0423198B1 (fr)	1996-05-08	Anticorps specifiques envers hiv 1 gp 48
EP0400245B1 (fr)	1995-12-20	Protéines et glycoprotéines du retrovirus HIV-2 EHO, anticorps dirigés contre eux, application pour le diagnostic
CA2160922C (fr)	2007-03-13	Complexes immunogenes pour la detection du hiv

Legal Events

Date	Code	Title	Description
2016-07-20	MKEX	Expiry	Effective date: 20160518